Argenx Se (ARGX) Change in Cash (2015 - 2023)
Argenx Se's (ARGX) quarterly Change in Cash came in at $488.9 million in Q2 2023, up 168.45% YoY from $182.1 million in Q2 2022, and up 364.22% on a QoQ basis from -$185.0 million in Q1 2023.
Argenx Se (ARGX) Change in Cash (2015 - 2023) Analysis & Trends
Argenx Se (ARGX) has 5 years of Change in Cash data on file, last reported at $488.9 million in Q2 2023.
- Quarterly Change in Cash rose 168.45% year-over-year to $488.9 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $979.7 million (up 336.61% YoY) and the FY2025 annual result came in at $1.9 billion, up 465.4% from the prior year.
- Change in Cash grew to $488.9 million in Q2 2023, from -$185.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $1.2 billion in Q3 2022 to a low of -$714.2 million in Q2 2022.
- A 4-year average of $160.1 million and a median of $105.2 million in 2020 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2021 — Change in Cash sank 992.91% — and 2022, when it surged 684.14%.
- Tracing ARGX's Change in Cash over 4 years: stood at $58.8 million in 2020, then tumbled by 729.43% to -$370.1 million in 2021, then plunged by 38.57% to -$512.8 million in 2022, then surged by 195.34% to $488.9 million in 2023.
- The last three Change in Cash figures came in at $488.9 million (Q2 2023), -$185.0 million (Q1 2023), and -$512.8 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -170.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 488.90 Mn |
| Mar 31, 2023 | -185.04 Mn |
| Dec 31, 2022 | -512.80 Mn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | -714.24 Mn |
| Mar 31, 2022 | 518.66 Mn |
| Dec 31, 2021 | -370.06 Mn |
| Sep 30, 2021 | 151.58 Mn |
| Jun 30, 2021 | -524.97 Mn |
| Mar 31, 2021 | 910.90 Mn |
| Jun 30, 2020 | 58.79 Mn |
| Mar 31, 2020 | 910.90 Mn |
| Dec 31, 2015 | 11.27 Bn |